Yifan Xinfu Pharmaceutical Co Ltd (002019) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yifan Xinfu Pharmaceutical Co Ltd (002019) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥40.18 Million ≈ $5.88 Million USD) by net assets (CN¥8.71 Billion ≈ $1.27 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Yifan Xinfu Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Yifan Xinfu Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Yifan Xinfu Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yifan Xinfu Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yifan Xinfu Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Yifan Xinfu Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PHARVARIS N.V. EO -12
F:9EN
|
-0.140x |
|
FLEX LNG Ltd
NYSE:FLNG
|
0.014x |
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SHG:600063
|
0.005x |
|
Pebblebrook Hotel Trust
NYSE:PEB
|
0.033x |
|
Molymet
SN:MOLYMET
|
0.325x |
|
China Tianying Inc
SHE:000035
|
0.013x |
|
China Aluminum International Engineering Corp Ltd
SHG:601068
|
0.031x |
|
DCM Shriram Limited
NSE:DCMSHRIRAM
|
0.197x |
Annual Cash Flow Conversion Efficiency for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Yifan Xinfu Pharmaceutical Co Ltd from 2003 to 2025. View Yifan Xinfu Pharmaceutical Co Ltd stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥8.71 Billion ≈ $1.27 Billion |
CN¥458.37 Million ≈ $67.07 Million |
0.053x | -30.80% |
| 2024-12-31 | CN¥8.43 Billion ≈ $1.23 Billion |
CN¥640.73 Million ≈ $93.76 Million |
0.076x | +80.06% |
| 2023-12-31 | CN¥8.25 Billion ≈ $1.21 Billion |
CN¥348.58 Million ≈ $51.01 Million |
0.042x | -18.18% |
| 2022-12-31 | CN¥9.15 Billion ≈ $1.34 Billion |
CN¥472.07 Million ≈ $69.08 Million |
0.052x | +50.34% |
| 2021-12-31 | CN¥8.78 Billion ≈ $1.28 Billion |
CN¥301.23 Million ≈ $44.08 Million |
0.034x | -73.01% |
| 2020-12-31 | CN¥8.72 Billion ≈ $1.28 Billion |
CN¥1.11 Billion ≈ $162.21 Million |
0.127x | +6.13% |
| 2019-12-31 | CN¥7.82 Billion ≈ $1.14 Billion |
CN¥937.24 Million ≈ $137.15 Million |
0.120x | -29.51% |
| 2018-12-31 | CN¥6.89 Billion ≈ $1.01 Billion |
CN¥1.17 Billion ≈ $171.34 Million |
0.170x | +1.79% |
| 2017-12-31 | CN¥6.78 Billion ≈ $992.46 Million |
CN¥1.13 Billion ≈ $165.75 Million |
0.167x | -23.88% |
| 2016-12-31 | CN¥3.90 Billion ≈ $570.77 Million |
CN¥855.85 Million ≈ $125.24 Million |
0.219x | +57.24% |
| 2015-12-31 | CN¥2.88 Billion ≈ $421.52 Million |
CN¥401.96 Million ≈ $58.82 Million |
0.140x | +154.00% |
| 2014-12-31 | CN¥2.54 Billion ≈ $372.19 Million |
CN¥139.74 Million ≈ $20.45 Million |
0.055x | -38.38% |
| 2013-12-31 | CN¥384.95 Million ≈ $56.33 Million |
CN¥34.32 Million ≈ $5.02 Million |
0.089x | +43.45% |
| 2012-12-31 | CN¥480.81 Million ≈ $70.36 Million |
CN¥29.88 Million ≈ $4.37 Million |
0.062x | +155.24% |
| 2011-12-31 | CN¥469.52 Million ≈ $68.71 Million |
CN¥-52.82 Million ≈ $-7.73 Million |
-0.113x | -134.03% |
| 2010-12-31 | CN¥703.64 Million ≈ $102.96 Million |
CN¥-33.82 Million ≈ $-4.95 Million |
-0.048x | -174.89% |
| 2009-12-31 | CN¥913.15 Million ≈ $133.62 Million |
CN¥58.61 Million ≈ $8.58 Million |
0.064x | -56.02% |
| 2008-12-31 | CN¥570.87 Million ≈ $83.54 Million |
CN¥83.31 Million ≈ $12.19 Million |
0.146x | -67.81% |
| 2007-12-31 | CN¥548.55 Million ≈ $80.27 Million |
CN¥248.71 Million ≈ $36.39 Million |
0.453x | +351.02% |
| 2006-12-31 | CN¥324.46 Million ≈ $47.48 Million |
CN¥32.62 Million ≈ $4.77 Million |
0.101x | +33.73% |
| 2005-12-31 | CN¥320.93 Million ≈ $46.96 Million |
CN¥24.12 Million ≈ $3.53 Million |
0.075x | -30.63% |
| 2004-12-31 | CN¥309.98 Million ≈ $45.36 Million |
CN¥33.59 Million ≈ $4.91 Million |
0.108x | -19.25% |
| 2003-12-31 | CN¥94.31 Million ≈ $13.80 Million |
CN¥12.65 Million ≈ $1.85 Million |
0.134x | -- |
About Yifan Xinfu Pharmaceutical Co Ltd
Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provi… Read more